Preventing Attacks and Long-Term Care

Because the “leak” phase of Systemic Capillary Leak Syndrome (SCLS) can be life-threatening and unpredictable, the most effective way to manage primary (idiopathic) SCLS is to prevent attacks before they start. For these patients, long-term prophylaxis (preventative therapy) under specialist supervision is the mainstay of care ^[1][2].

The Mainstay of Prevention: Monthly IVIG

Intravenous Immunoglobulin (IVIG) is widely used and has the strongest observational support for preventing SCLS flares. IVIG is a product made from the antibodies of thousands of healthy donors, and it is typically given as a high-dose infusion once every month ^[3][4].

• Dosing: A commonly reported specialist regimen is between 1 and 2 grams per kilogram of body weight, administered once every 4 weeks ^[3][4]. However, this is not a universal prescription. The exact dose, interval, and product require careful specialist decisions based on your kidney function, tolerability, and individual risks.
• Observational Outcomes: While these are observational registry studies rather than randomized trials, data shows that IVIG has significantly changed the outlook for SCLS patients. In large cohorts, patients receiving preventative IVIG had far fewer attacks and notably better survival rates compared to historically untreated patients ^[2]. In the European EurêClark registry, IVIG was associated with improved long-term survival ^[5].
• How it Works: While scientists are still researching exactly why IVIG helps, it is believed to help stabilize the immune system and protect the lining of the capillaries from the inflammatory triggers that cause them to open ^[1][6].
• Safety Advice: IVIG has important side effects. You should seek urgent medical care if you experience severe headaches, neck stiffness, chest pain, one-sided limb swelling, markedly reduced or dark urine, breathing difficulty, or a severe allergic reaction during or after an infusion.

Alternative Oral Preventative Options

Before IVIG became widely used, doctors relied on oral medications to help prevent flares. These are now considered specialist-directed alternatives with limited evidence ^[2][7].

• Terbutaline: This is a beta-agonist that may help strengthen the “junctions” between capillary cells, making them less likely to leak ^[8]. Some observational data associated it with lower mortality ^[5].
• Theophylline: This is a methylxanthine that works through a similar mechanism. It has been used for decades but requires careful blood monitoring because it has a narrow “toxic range” ^[1][8].

Warning: These older medications can cause clinically important side effects, including rapid heart rate (tachycardia), severe tremors, low potassium, rhythm problems, and toxicity. You should never start, stop, or adjust these medications without direct specialist monitoring.

The Danger of Stopping Treatment

You should never abruptly stop your preventative treatment, even if you have been stable for many years.

Data from the EurêClark registry highlights the risks of withdrawing IVIG therapy. In a retrospective study of 59 adults, those who withdrew from IVIG treatment had a significantly lower 10-year survival rate (50%) compared to those who stayed on their treatment (83%) ^[4]. Patients who stopped treatment also experienced more frequent and severe relapses ^[4].

If a change in treatment is necessary—due to side effects or other medical needs—it must be done through cautious tapering under the strict supervision of an SCLS specialist. There is no universally established withdrawal schedule, and any trial of reduction must be highly individualized ^[4]. If your access to IVIG is interrupted by insurance or supply issues, contact your specialist urgently.

Long-Term Monitoring

Because many adults with SCLS also have a monoclonal protein (M-spike), long-term care involves more than just preventing leaks. You will likely need:

• Regular Blood Work: Monitoring for changes in the M-spike, as well as kidney function and blood counts ^[5].
• Infusion Monitoring: Checking for side effects from IVIG and ensuring your renal (kidney) function remains healthy ^[4][9].
• Specialist Coordination: Ensuring your local hematologist or immunologist is in contact with one of the few global “centers of excellence” for SCLS to stay updated on the latest treatment protocols ^[10][9].